As filed with the Securities and Exchange Commission on April 11 , 2008
Registration No. 333-   131605

 
UNITED STATES SECURITIES AND EXCHANGE
COMMISSION
 
WASHINGTON, D.C. 20549

Post-effective Amendment No. 6 to

FORM SB-2
 
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933

  
SCI ENGINEERED MATERIALS, INC.
 
(Exact name of registrant as specified in its charter)
 
Ohio
 
2899
 
31-1210318
(State or other jurisdiction of
incorporation or organization)
 
(Primary standard industrial
classification number)
 
(IRS employer
identification number)

2839 Charter Street
Columbus, Ohio 43228
(614) 486-0261
(Address and telephone number of principal executive offices)

2839 Charter Street
Columbus, Ohio 43228
(Address of principal place of business)

Daniel Rooney, Chief Executive Officer
SCI Engineered Materials, Inc.
2839 Charter Street
Columbus, Ohio 43228
(614) 486-0261
(Name, address and telephone number of agent for service)

 
Copies to:

Michael A. Smith, Esq.
Carlile Patchen & Murphy LLP
366 E. Broad Street
Columbus, Ohio 43215
Telephone No. (614) 628-0798
Telecopier No. (614) 221-0216
 
Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.
 
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. x
 
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act Registration Statement number of the earlier effective Registration Statement for the same offering. o
 
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act Registration Statement number of the earlier effective Registration Statement for the same offering. o
 
If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act Registration Statement number of the earlier effective Registration Statement for the same offering. o
 
If delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box. o
 
The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effectiveness until the registrant shall file a further amendment which states that that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
 

PROSPECTUS
 
SCI ENGINEERED MATERIALS, INC.
 
2,281,253 Shares of Common Stock
 
This prospectus relates to the sale of up to 2,281,253 shares of our common stock by persons who have purchased shares of our common stock or who may purchase shares of our common stock through the exercise of warrants as more fully described herein. The aforementioned persons are sometimes referred to in this prospectus as the Selling Shareholders. The prices at which the Selling Shareholders may sell the shares will be determined by the prevailing market price for the shares or in negotiated transactions. We will not receive proceeds from the sale of our shares by the Selling Shareholders.
 
We have amended our original prospectus to incorporate financial information for the   year ended December 31, 2007.
 
Our common stock is quoted on the Over-The-Counter Bulletin Board under the symbol SCCI. On March 20, 2008, the last reported sale price for our common stock as reported on the Over-The-Counter Bulletin Board was $ 3.20 per share.
 
The mailing address for the Company’s principal executive offices is 2839 Charter Street, Columbus, Ohio 43228. The phone number for Company’s principal executive offices is (614) 486-0261.
 

 
Each selling shareholder may be considered an “underwriter” within the meaning of the Securities Act of 1933, as amended.
 
THE SECURITIES OFFERED IN THIS PROSPECTUS INVOLVE A HIGH DEGREE OF RISK. YOU SHOULD CONSIDER THE RISK FACTORS BEGINNING ON PAGE 3 BEFORE PURCHASING OUR COMMON STOCK.
 
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
 

 
The date of this prospectus is  April 10 , 2008.
 


Table of Contents
 

 
Prospectus Summary
  
1-2
     
Risk Factors
 
3-5
     
Use Of Proceeds
 
5
     
Cautionary Note Regarding Forward-Looking Statements
 
6
     
Selling Shareholders
 
7-9
     
Plan of Distribution
 
9-11
     
Our Management
 
11-15
     
Security Ownership of Certain Beneficial Owners And Management
 
15-16
     
Description of Securities
 
16-18
     
Interest of Named Experts and Counsel
 
18
     
Disclosure of Commission Position on Indemnification for Securities Act Liabilities
 
18-20
     
Description of Business
 
20-25
     
Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
2 5-29
     
Description of Property
 
29
     
Certain Relationships and Related Transactions
 
29-31
     
Market for Common Equity and Related Shareholder Matters
 
3 1
     
Executive Compensation
 
3 2
     
Equity Compensation Plan Information
 
38
     
Legal Opinion
 
38
     
Experts
 
38
     
Index to Financial Statements
 
F-1

Unless otherwise specified, the information in this prospectus is set forth as of March 31, 2008 , and we anticipate that changes in our affairs will occur after such date. We have not authorized any person to give any information or to make any representations, other than as contained in this prospectus, in connection with the offer contained in this prospectus. If any person gives you any information or makes representations in connection with this offer, do not rely on it as information we have authorized. This prospectus is not an offer to sell our common stock in any state or other jurisdiction to any person to whom it is unlawful to make such offer.


PROSPECTUS SUMMARY
 
The following summary highlights selected information from this prospectus and may not contain all the information that is important to you. To understand our business and this offering fully, you should read this entire prospectus carefully, including the financial statements and the related notes beginning on page F-1. When we refer in this prospectus to the “company,” “we,” “us,” and “our,” we mean SCI Engineered Materials, Inc., an Ohio corporation. This prospectus contains forward-looking statements and information relating to SCI Engineered Materials, Inc. See Cautionary Note Regarding Forward Looking Statements on page 6.
 
Our Company
 
Our company was incorporated on May 29, 1987, to develop, manufacture and market products based on or incorporating high temperature superconductive (“HTS”) materials. HTS materials are complex metal oxides – ceramics of certain stoichiometries (chemical mixture ratios), which exhibit superconducting phenomena when cooled to at least –196(degrees) Centigrade.
 
We recently amended our Articles of Incorporation to SCI Engineered Materials, Inc. from Superconductive Components, Inc. which is the name that we have used for business purposes for several years. We control the manufacturing process and measure performance in terms of sales, in two categories, Ceramics and Metals, as the products sold are easily separable into these categories. The performance measurements made in these two categories are, however, not conducive to segment reporting as there are many shared operating expenses relating to the production of both Ceramic and Metals that cannot be attributed solely to one or the other.
 
We view our business as supplying ceramic and metal materials to a variety of industrial applications including: Semiconductor, Photonics/Optical, Solar and Thin Film Batteries. The production and sale of High Temperature Superconducting (HTS) materials was the initial focus of our operations and these materials continue to be a part of our development efforts. We continue to seek funded research to develop new and improved products for future applications of HTS Materials.
 
Optical/Photonics currently represents the largest market for our materials. Our customers are device manufacturers who are regularly identifying new materials that improve the utility of optical/photonics coating. This includes materials that improve the ability of optical/photonics coatings to focus or filter light, and coatings that improve wear and chemical attack resistance, all of which increases the potential demand for the types and amounts of materials that we sell in this market. Photonic applications continue to expand as new methods are found to manipulate light waves to enhance the various properties of light the device manufacturers are seeking. During late 2007, we added a sales engineer to focus on the expanding demand for Thin Film Solar materials. In late 2006, we added a marketing manager to sell our product to the semiconductor industry.
 
Thin Film Battery materials is a developing market where manufacturers of batteries use these materials to produce very small power supplies, with small quantities of stored energy. A typical Thin Film Battery would be produced via Physical Vapor Deposition (PVD) with five or more thin layers. These batteries are often one centimeter square but only 15 microns thick. Potential applications for these batteries include, but are not limited to: active RFID tags, battery on chip, portable electronics, and medical implant devices.
 
The Offering
 
We have filed a Registration Statement on Form SB-2 with the Securities and Exchange Commission with respect to the securities offered in this prospectus. The Registration Statement became effective April 4, 2006 and continues to be effective. The Registration Statement allows the Selling Shareholders and any of their pledgees, donees, transferees, assignees and successors-in-interest may, from time to time, sell any or all of their registered shares of common stock on any stock exchange, market or trading facility on which the registered shares are traded or in private transactions. These sales may be at fixed or negotiated prices. However, the Selling Stockholders listed in this prospectus may choose not to sell any of their registered shares, and may have no intention of selling any securities offered pursuant to this prospectus in the near future. Additionally, we have no reason to believe that any Selling Shareholder has entered into an agreement, or made a commitment to sell any securities offered in this prospectus.


Common stock offered by the
 
Selling Shareholders
  
2,281,253 shares
     
Termination of the offering
 
The offering will conclude when all of the 2,281,253 shares of common stock have been sold, the shares no longer need to be registered or we decide to terminate the registration of the shares.
     
Terms of the offering
 
The Selling Shareholders will determine when and how they will sell the common stock offered in this prospectus.
     
Common stock outstanding as of March 31, 2008
 
3,501,966 shares
     
Use of Proceeds
 
We will not receive any proceeds from the sale of the common stock.
 
An investment in our common stock is highly speculative and involves a high degree of risk. See Risk Factors beginning on page 3.

2

RISK FACTORS  
 
An investment in our common stock is highly speculative, involves a high degree of risk, and should be made only by investors who can afford a complete loss. You should carefully consider the following risk factors, together with the other information in this prospectus, including our financial statements and the related notes, before you decide to buy our common stock. Our most significant risks and uncertainties are described below; however, they are not the only risks we face. If any of the following risks actually occur, our business, financial condition, or results of operations could be materially adversely affected, the trading of our common stock could decline, and you may lose all or part of your investment therein.
 
We have experienced significant operating losses in the past and may continue to do so in the future.
 
We commenced business in May of 1987. We reported net income applicable to common shares of $277,083 for the year ended December 31, 2006, and $307,682 for the year ended December 31, 2007 . There can be no assurance that we will continue to be profitable. Our accumulated deficit since inception was $ 7,526,426 at De cembe r 31, 2007.
 
We have financed the losses primarily from additional investments and loans by our major shareholders and private offerings of common stock and warrants to purchase common stock in 2004 and 2005. We cannot assure you, however, that we will be able to raise additional capital in the future to fund our operations.
 
We have limited marketing and sales capabilities.
 
We hired a full time sales engineer in 2007 and a full time marketing manager in 2006, to expand our marketing activities, especially in the solar area of the photonics market and in the semiconductor market. To successfully market our products, we must continue to develop appropriate marketing, sales, technical, customer service and distribution capabilities, or enter into agreements with third parties to provide these services. Our failure to develop these capabilities or obtain third-party agreements could adversely affect us.
 
Our success depends on our ability to retain key management personnel.
 
Our success depends in large part on our ability to attract and retain highly qualified management, administrative, manufacturing, sales, and research and development personnel. Due to the specialized nature of our business, it may be difficult to locate and hire qualified personnel. The loss of the services of one of our executive officers or other key personnel, or our failure to attract and retain other executive officers or key personnel, could have a material adverse effect on our business, operating results and financial condition. Although we have been successful in planning for and retaining highly capable and qualified successor management in the past, there can be no assurance that we will be able to do so in the future.
 
We may need to seek additional capital in the future, which may reduce the value of our common stock.
 
We reported net income of $277,083 for 2006 and $307,682 for 2007. We incurred substantial operating losses prior to 2006. There is no assurance that our profitable operations will continue and we could be required to seek additional capital in the future for growth and working capital purposes as well. There is no assurance that new capital will be available or that it will be available on terms that will not result in substantial dilution or reduction in value of our common stock.
 
Our competitors have far greater financial and other resources than we have.
 
The market for Physical Vapor Deposition materials is a substantial market with significant competition in both ceramic and metal materials. While we believe that our products enjoy certain competitive advantages in design, function, quality, and availability, considerable competition exists from well-established firms, such as Williams Advanced Materials, Kurt Lesker and Tosoh, all of which have more resources than we have. We cannot provide assurance that developments by others will not render our products or technologies obsolete or less competitive.

3

Our revenues depend on patents and proprietary rights that may not be enforceable.
 
We rely on a combination of patent and trademark law, license agreements, internal procedures and nondisclosure agreements to protect our intellectual property. These may be invalidated, circumvented or challenged. In addition, the laws of some foreign countries in which our products may be produced or sold do not protect our intellectual property rights to the same extent as the laws of the United States. Our failure to protect our proprietary information could adversely affect us.
 
Rights we have to patents and pending patent applications may be challenged.
 
We have received from the United States Patent and Trademark Office a patent for Fine-Particle Bi-Sr-Ca-Cu-O Having High Phase Purity made by a Chemical Precipitation and Low-Pressure Calcination method, and have also received a patent for a process to join two individual strongly linked super-conductors utilizing a melt processing technique. In the future, we may submit additional patent applications covering various applications. The patent application we filed and patent applications that we may file in the future may not result in patents being issued, and any patents issued may not afford meaningful protection against competitors with similar technology, and may be challenged by third parties. Because U.S. patent applications are maintained in secret until patents are issued, and because publications of discoveries in the scientific or patent literature tend to lag behind actual discoveries by several months, we may not be the first creator of inventions covered by issued patents or pending patent applications or the first to file patent applications for such inventions. Moreover, other parties may independently develop similar technologies, duplicate our technologies or, if patents are issued to us or rights licensed by us, design around the patented aspects of any technologies we developed or licensed. We may have to participate in interference proceedings declared by the U.S. Patent and Trademark Office to determine the priority of inventions, which could result in substantial costs. Litigation may also be necessary to enforce any patents held by or issued to us or to determine the scope and validity of others' proprietary rights, which could result in substantial costs.
 
The rapid technological changes of our industry may adversely affect us if we do not keep pace with advancing technology.
 
The Physical Vapor Deposition market is characterized by rapidly advancing technology. Our success depends on our ability to keep pace with advancing technology and processes and industry standards. To date, we have focused our development efforts on powders and targets. We intend to continue to develop and integrate advances in the thin film coatings industry. However, our development efforts may be rendered obsolete by research efforts and technological advances made by others, and materials other than those we currently use may prove more advantageous.
 
Development stage of our products and uncertainty regarding development of markets.
 
Some of our products are in the early stages of commercialization and we believe that it will be several years before products will have significant commercial end-use applications, and that significant additional development work may be necessary to improve the commercial feasibility and acceptance of its products. There can be no assurance that we will be able to commercialize any of the products currently under development.
 
To date, there has been no widespread commercial use of High Temperature Superconductive (HTS) products. Additionally, the market for the Thin Film Battery materials is still in its early stages. Some of our materials are in early stages of development for Thin Film Solar applications. Thin Film Solar is expected to gain significant market share during the next few years.

4

The market for our common stock is limited and, as such, our shareholders may have difficulty reselling their shares when desired or at attractive market prices.
 
Our stock price and our listing may make it more difficult for our shareholders to resell shares when desired or at attractive prices. In 2001, our stock began trading on The Over the Counter Bulletin Board (“OTC Bulletin Board”). Nevertheless, our common stock has continued to trade in low volumes and at low prices. Some investors view low-priced stocks as unduly speculative and therefore not appropriate candidates for investment. Many institutional investors have internal policies prohibiting the purchase or maintenance of positions in low-priced stocks.
 
This has the effect of limiting the pool of potential purchases of our common stock at present price levels. Shareholders may find greater percentage spreads between bid and asked prices, and more difficulty in completing transactions and higher transaction costs when buying or selling our common stock than they would if our stock were listed on a major stock exchange, such as The New York Stock Exchange or The Nasdaq National Market.
 
Prior to the fourth quarter of 2006, our common stock was subject to the Securities and Exchange Commission’s “penny stock” regulations, which limits the liquidity of common stock held by our shareholders.
 
Based on its trading prior to the fourth quarter of 2006, our common stock was considered a “penny stock” for purposes of federal securities laws, and therefore was subject to regulations which affected the ability of broker-dealers to sell our securities. During 2007 our stock traded above the penny stock threshold but has recently once again slipped below the threshold. Broker-dealers who recommend a “penny stock” to persons (other than established customers and accredited investors) must make a special written suitability determination and receive the purchaser’s written agreement to a transaction prior to sale. There can be no assurance that our common stock will once again rise above the penny stock threshold or follow below the threshold in the future.
 
During times when the penny stock regulations apply to our stock, it may be difficult to trade such stock because compliance with the regulations can delay and/or preclude certain trading transactions. Broker-dealers may be discouraged from effecting transactions in our common stock because of the sales practice and disclosure requirements for penny stock. This could adversely affect the liquidity and/or price of our common stock, and impede the sale of our common stock in the secondary market.
 
Our Articles of Incorporation authorize us to issue additional shares of stock.
 
We are authorized to issue up to 15,000,000 shares of common stock, which may be issued by our board of directors for such consideration as they may consider sufficient without seeking shareholder approval. The issuance of additional shares of common stock in the future will reduce the proportionate ownership and voting power of current shareholders.
 
Our Articles of Incorporation authorize us to issue up to 260,000 shares of preferred stock. The issuance of preferred stock in the future could create additional securities which would have dividend and liquidation preferences prior in right to the outstanding shares of common stock. These provisions could also impede a non-negotiated change in control.
 
We have not paid dividends on our common stock in the past and do not expect to do so in the future.
 
We cannot assure you that our operations will result in sufficient revenues to enable us to operate at profitable levels or to generate positive cash flow sufficient to pay dividends. We have never paid dividends on our common shares in the past and do not expect to do so in the foreseeable future.
 
USE OF PROCEEDS
 
This prospectus relates to shares of our common stock that may be offered and sold from time to time by the Selling Shareholders. We will receive no proceeds from the sale of shares of common stock in this offering.

5

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
 
This prospectus contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. In this prospectus, we use words such as “anticipates,” “believes,” “plans,” “expects,” “future,” “intends,” and similar expressions to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends affecting the financial condition of our business. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including, among other things:
 
 
·
general economic and business conditions, both nationally and in our markets,
 
·
our history of losses,
 
·
our expectations and estimates concerning future financial performance, financing plans and the impact of competition,
 
·
our ability to implement our growth strategy,
 
·
anticipated trends in our business,
 
·
advances in technologies, and
 
·
other risk factors set forth under “Risk Factors” in this prospectus.

We undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this prospectus. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this prospectus may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements.
 
[Remainder of page intentionally left blank]

6

SELLING SHAREHOLDERS
 
The following table presents information regarding the Selling Shareholders and the shares that may be sold by them pursuant to this prospectus. See also Security Ownership of Certain Beneficial Owners and Management.

Selling
Shareholders
 
Shares
Owned
Before
Offering
 
Percentage of
Outstanding
Shares
Owned Before
Offering (1)
 
Shares to
be Sold in
the Offering
 
Percentage
of
Outstanding
Shares
Owned
After
Offering (1)
 
Windcom Investments SA (2)
   
335,205
   
9.7
%
 
335,205
   
0
%
Lake Street Fund L.P.(3)
   
312,500
   
9.0
%
 
312,500
   
0
%
Berlin Capital Growth L.P.(4)
   
281,250
   
8.1
%
 
281,250
   
0
%
Mid South Investor Fund L.P. (5)
   
250,000
   
7.2
%
 
250,000
   
0
%
Robert Peitz (6)
   
301,790
   
8.6
%
 
252,016
   
1.4
%
Thomas Berlin (7)
   
406,250
   
11.6
%
 
125,000
   
0
%
Daniel Funk (8)
   
150,125
   
4.3
%
 
119,716
   
*
 
Laura Shunk (9)
   
158,255
   
4.6
%
 
119,716
   
1.1
%
The Estate of Edward R. Funk (10)
   
437,256
   
12.3
%
 
117,500
   
8.8
%
James Chapman (11)